BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14636479)

  • 1. Human herpesvirus-8 (HHV-8) antibodies in women from São Paulo, Brazil. Association with behavioral factors and Kaposi's sarcoma.
    Caterino-De-Araujo A; de los Santos-Fortuna E; Carbone PH; Cibella SE; Moreira AA
    Braz J Infect Dis; 2003 Dec; 7(6):395-401. PubMed ID: 14636479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for antibodies to HHV-8 in children born to HIV-1 infected mothers from São Paulo, Brazil: relationship to maternal infection.
    Caterino-de-Araujo A; Cibella SE
    J Trop Pediatr; 2003 Aug; 49(4):247-50. PubMed ID: 12929889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lennette ET; Blackbourn DJ; Levy JA
    Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in São Paulo State.
    Souza VA; Sumita LM; Freire W; Sato HK; Grandi JL; Pierrotti LC; Nascimento MC; Pannuti CS
    Braz J Med Biol Res; 2004 Jan; 37(1):123-7. PubMed ID: 14689053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections.
    Rezza G; Lennette ET; Giuliani M; Pezzotti P; Caprilli F; Monini P; Buttò S; Lodi G; Di Carlo A; Levy JA; Ensoli B
    Int J Cancer; 1998 Jul; 77(3):361-5. PubMed ID: 9663596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
    Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
    Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 8 (HHV-8) detected by nested polymerase chain reaction (PCR) in HIV patients with or without Kaposi's sarcoma. An analytic cross-sectional study.
    Machado PR; Farias KJ; Pereira MG; Freitas PP; Fonseca BA
    Sao Paulo Med J; 2015 Apr; 134(3):187-92. PubMed ID: 25885486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HHV-8 infection in patients with AIDS-related Kaposi's sarcoma in Brazil.
    Keller R; Zago A; Viana MC; Bourboulia D; Desgranges C; Casseb J; Moura WV; Dietze R; Collandre H
    Braz J Med Biol Res; 2001 Jul; 34(7):879-86. PubMed ID: 11449306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma.
    Cattani P; Capuano M; Cerimele F; La Parola IL; Santangelo R; Masini C; Cerimele D; Fadda G
    J Clin Microbiol; 1999 Apr; 37(4):1150-3. PubMed ID: 10074540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
    Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
    AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
    Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
    Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A; Magri MC; Manuel RC
    J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against human herpesvirus 8 in black South African patients with cancer.
    Sitas F; Carrara H; Beral V; Newton R; Reeves G; Bull D; Jentsch U; Pacella-Norman R; Bourboulia D; Whitby D; Boshoff C; Weiss R
    N Engl J Med; 1999 Jun; 340(24):1863-71. PubMed ID: 10369849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of BC-3 and BCP-1 cell lines in immunofluorescence assay to detect HHV-8 antibodies in Kaposi's sarcoma, multiple myeloma and other groups.
    Couty JP; Ranger-Rogez S; Venot C; Jaccard A; Rogez JP; Weinbreck P; Bordessoule D; Denis F
    J Clin Virol; 1999 May; 12(3):221-31. PubMed ID: 10382819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
    Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
    Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.